Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Wason

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
BMC Cancer|November 19, 2021
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocolStephan Ursprung, Helen Mossop, Ferdia A Gallagher, et al.
BMJ Medicine|February 27, 2026
Making clinical guidelines work for people with multiple long term conditions: analysis and recommendations from review of single condition guidelinesSara Pretorius, Victoria Bartle, Sue Bellass, et al.
BMJ Open|March 11, 2026
Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acidSarah Dunn, Lysbeth Evans, Ciara Kennedy, et al.
Evidence-Based Mental Health|May 16, 2022
Components of smartphone cognitive-behavioural therapy for subthreshold depression among 1093 university students: a factorial trialMasatsugu Sakata, Rie Toyomoto, Kazufumi Yoshida, et al.
Lancet (London, England)|May 25, 2026
The Lancet Commission on precision health: equitable, data-driven health outcomes for allPaul W Franks, Lee-Ling Lim, Michèle Ramsay, et al.
Radiology. Imaging Cancer|July 15, 2022
Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-<sup>13</sup>C]Pyruvate Demonstrates Heterogeneity in Lactate Labeling: A Proof of Principle StudyFulvio Zaccagna, Mary A McLean, James T Grist, et al.
European Journal of Human Genetics : EJHG|March 19, 2009
Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factorMaria Ban, An Goris, Aslaug R Lorentzen, et al.
BMJ Open|September 21, 2025
Finding the optimal regimen for <i>Mycobacteroides abscessus</i> treatment (FOR<i>Ma</i>T) in people with <i>Mycobacteroides abscessus</i> pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trialTiffany Jong, Timothy Baird, Helen Louise Barr, et al.
Cancer Research|October 9, 2021
Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer PatientsRamona Woitek, Mary A McLean, Stephan Ursprung, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2020
Imaging breast cancer using hyperpolarized carbon-13 MRIFerdia A Gallagher, Ramona Woitek, Mary A McLean, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
BMC Cancer|November 19, 2021
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocolStephan Ursprung, Helen Mossop, Ferdia A Gallagher, et al.
BMJ Medicine|February 27, 2026
Making clinical guidelines work for people with multiple long term conditions: analysis and recommendations from review of single condition guidelinesSara Pretorius, Victoria Bartle, Sue Bellass, et al.
BMJ Open|March 11, 2026
Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acidSarah Dunn, Lysbeth Evans, Ciara Kennedy, et al.
Evidence-Based Mental Health|May 16, 2022
Components of smartphone cognitive-behavioural therapy for subthreshold depression among 1093 university students: a factorial trialMasatsugu Sakata, Rie Toyomoto, Kazufumi Yoshida, et al.
Lancet (London, England)|May 25, 2026
The Lancet Commission on precision health: equitable, data-driven health outcomes for allPaul W Franks, Lee-Ling Lim, Michèle Ramsay, et al.
Radiology. Imaging Cancer|July 15, 2022
Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-<sup>13</sup>C]Pyruvate Demonstrates Heterogeneity in Lactate Labeling: A Proof of Principle StudyFulvio Zaccagna, Mary A McLean, James T Grist, et al.
European Journal of Human Genetics : EJHG|March 19, 2009
Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factorMaria Ban, An Goris, Aslaug R Lorentzen, et al.
BMJ Open|September 21, 2025
Finding the optimal regimen for <i>Mycobacteroides abscessus</i> treatment (FOR<i>Ma</i>T) in people with <i>Mycobacteroides abscessus</i> pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trialTiffany Jong, Timothy Baird, Helen Louise Barr, et al.
Cancer Research|October 9, 2021
Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer PatientsRamona Woitek, Mary A McLean, Stephan Ursprung, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2020
Imaging breast cancer using hyperpolarized carbon-13 MRIFerdia A Gallagher, Ramona Woitek, Mary A McLean, et al.
Pageof 10